Agios Pharmaceuticals Inc (NAS:AGIO)
$ 60.48 1.42 (2.4%) Market Cap: 3.45 Bil Enterprise Value: 2.42 Bil PE Ratio: 5.32 PB Ratio: 2.12 GF Score: 37/100

Agios Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript

Jan 12, 2022 / 12:30PM GMT
Release Date Price: $31.64 (-4.61%)
Anupam Rama
JPMorgan Chase & Co, Research Division - VP and Analyst

Welcome, everyone, to the 40th Annual J.P. Morgan Healthcare Conference. My name is Anupam Rama, I'm one of the senior biotech analysts here at JPMorgan. I'm joined by Caleb Smith, [Malcolm Kuno] and Priyanka Grover from the team. Our next presenting company is Agios, and presenting on behalf of the company, we have CEO, Jackie Fouse. I want to remind all the listeners of this session that there is an ask a question feature in the portal. And if you'd like to put a question in the portal, I would be happy to ask on your behalf.

With that, Jackie, take it away.

Jacqualyn A. Fouse
Agios Pharmaceuticals, Inc. - CEO & Director

Good morning, everybody. Thanks, Anupam. Great to be here with you this morning, and thanks for attending our presentation. I am sharing slides on the screen, and so I'm going to drive those slides. And for those of you who may want to follow along on your own, you can do that as well and you can see my slides on the screen and follow along with those.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot